Date | Title | Description | Source |
26.01.2024 | New milestones for life sciences startups |
BioVersys AG is a clinical stage, multi-asset Swiss pharmaceutical company focusing on research and... | startuptic... |
12.12.2023 | FDA grants BioVersys orphan-drug designation | | startuptic... |
09.11.2023 | Newly appointed executives to make startups top notch | | startuptic... |
10.05.2023 | Biotech startups turn gear into Phase 2 clinical trials | | startuptic... |
28.04.2023 | Swiss Accelerator: Innosuisse supports 53 companies with CHF... | | startuptic... |
06.01.2023 | BioVersys Extends its Series C Round to CHF 32.6M | BioVersys, a Basel, Switzerland-based privately held clinical stage, multi-asset pharmaceutical comp... | finsmes.co... |
05.01.2023 | BioVersys raises CHF 32.6 million in extended Series C round | BioVersys AG is a privately held clinical-stage, multi-asset Swiss pharmaceutical company focusing o... | venturekic... |
05.01.2023 | BioVersys secures an additional CHF 8.4 million to advance c... | | startuptic... |
05.01.2023 | BioVersys raises CHF 32.6 million in extended Series C round | BioVersys raises CHF 32.6 million in extended Series C round 05.01.2023 13:15, Morgane Ghilardi link... | venturelab... |
20.09.2022 | Applauses for Swiss Innovators | | startuptic... |
21.06.2022 | Second successful Phase I trial for BioVersys | | startuptic... |
08.06.2022 | BioVersys closes a CHF 24.2 million financing round to devel... | BioVersys closes a CHF 24.2 million financing round to develop AMR medical pipeline 08.06.2022 09:00... | venturelab... |
08.06.2022 | BioVersys closes a CHF 24.2 million financing round to devel... | The confidence of their investors and the renewed interest of established pharma and biotech compani... | venturekic... |
08.06.2022 | BioVersys attracts CHF 24.2 million to develop clinical pipe... | | startuptic... |
02.06.2022 | Sparks IPO Academy completes first edition with 13 companies | | startuptic... |
03.05.2022 | BioVersys' BV100 advances into phase II clinical trials | | startuptic... |
01.06.2021 | BioVersys secures additional funding | BioVersys AG is a multi-asset Swiss pharmaceutical company focusing on developing small molecules fo... | startuptic... |
01.06.2021 | BioVersys gets up to USD 15.34 million CARB-X grant to furth... | BioVersys AG, a privately owned clinical-stage, multi-asset Swiss pharmaceutical company focusing on... | venturekic... |
01.06.2021 | BioVersys secures additional funding | | startuptic... |
01.06.2021 | BioVersys gets up to USD 15.34 million CARB-X grant to furth... | BioVersys gets up to USD 15.34 million CARB-X grant to further develop pyrrolocytosines, a novel cla... | venturelab... |
15.04.2021 | BioVersys receives €20 million in EU financing to develop ne... | BioVersys AG is a clinical-stage pharmaceutical company developing treatments for multidrug-resistan... | startuptic... |
15.04.2021 | BioVersys receives €20 million in EU financing to develop ne... | | startuptic... |
14.04.2021 | BioVersys receives EUR 20 million in EU financing to support... | The European Investment Bank (EIB) and BioVersys AG, a clinical-stage pharmaceutical company develop... | venturekic... |
14.04.2021 | BioVersys receives EUR 20 million in EU financing to support... | BioVersys receives EUR 20 million in EU financing to support the development of new antibiotics 14.0... | venturelab... |
24.02.2021 | BioVersys and consortium partners obtain €2.7 million grant... | BioVersys AG is a privately owned, multi-asset Swiss pharmaceutical company focusing on research and... | startuptic... |
24.02.2021 | BioVersys and consortium partners obtain €2.7 million grant... | | startuptic... |
13.01.2021 | BioVersys’ second drug candidate enters clinical trials | BioVersys AG develops small molecules for multidrug-resistant bacterial infections. Having brought i... | startuptic... |
13.01.2021 | BioVersys’ second drug candidate enters clinical trials | | startuptic... |
08.01.2021 | BAS members invested a 7-digit amount in start-ups in 2020 | Normal 0 false false false DE-CH X-NONE X-NONE | startuptic... |
08.01.2021 | BAS members invested a 7-digit amount in start-ups in 2020 | Business Angels Switzerland is an association comprising private individuals that are willing to inv... | startuptic... |
19.11.2020 | BioVersys doses first subjects in Phase 1 clinical trial of ... | | startuptic... |
19.11.2020 | BioVersys doses first subjects in Phase 1 clinical trial of ... | BioVersys is a privately owned, multi-asset Swiss pharmaceutical company focused on developing small... | startuptic... |
01.09.2020 | BioVersys Raises CHF 19M in Funding | BioVersys, a Basel, Switzerland-based pharmaceutical company, closed a CHF 19m Series B financing ro... | finsmes.co... |
01.09.2020 | A CHF 19 Million round brings BioVersys closer to clinical P... | BioVersys is a privately owned, multi-asset Swiss pharmaceutical company focusing on the development... | startuptic... |
01.09.2020 | A CHF 19 Million round brings BioVersys closer to clinical P... | | startuptic... |
01.09.2020 | BioVersys announces CHF 19 million financing round to advanc... | BioVersys was founded in 2008 and was a Venture Kick winner in the same year, a Venture Leader in 20... | venturekic... |
01.09.2020 | BioVersys announces CHF 19 million financing round to advanc... | BioVersys announces CHF 19 million financing round to advance novel AMR candidates into clinical dev... | venturelab... |
23.06.2020 | BioVersys prepares first in-human trials for anti-tuberculos... | Based in Basel, BioVersys is a privately owned, multi-asset Swiss pharmaceutical company focusing on... | startuptic... |
23.06.2020 | BioVersys prepares first in-human trials for anti-tuberculos... | | startuptic... |
24.01.2020 | Venture Kick to inject 5 million Swiss francs in 80 projects | | startuptic... |
24.01.2020 | Venture Kick to inject 5 million Swiss francs in 80 projects | Venture Kick is a philanthropic initiative that provides up to CHF 150,000 in seed funding to Swiss ... | startuptic... |
19.12.2019 | Global accolades for Swiss innovations | | startuptic... |
29.10.2019 | BioVersys obtains new funds for its fight against drug-resis... | | startuptic... |
24.10.2019 | Four Swiss startups to explore China | | startuptic... |
20.06.2019 | BioVersys receives a grant of €7 million | | startuptic... |
27.05.2019 | The FDA grants BioVersys preferential treatment | | startuptic... |
27.11.2018 | Schweizer Startups holen sich erfahrene Manager ins Boot | | startuptic... |
10.08.2018 | BioVersys s’implante à Lille pour intensifier la recherche e... | | startuptic... |
22.11.2017 | BioVersys AG raises CHF5 million in Series A2 round | | startuptic... |
08.03.2017 | Bioversys and Aptuit team up to fight antibiotic resistance | | startuptic... |
04.10.2016 | #vleaders China 2016: Meet Marc Gitzinger of BioVersys | #vleaders China 2016: Meet Marc Gitzinger of BioVersys 04.10.2016 10:00, Lara Rossi linkedIn faceboo... | venturelab... |
04.10.2016 | #vleaders China 2016: Meet Marc Gitzinger of BioVersys | Meet Marc Gitzinger, CEO of BioVersys
BioVersys focuses on research and development of small molecul... | venturekic... |
24.08.2016 | Ten new Swiss startups selected to conquer China and its inv... | Ten new Swiss startups selected to conquer China and its investors in 2016 24.08.2016 14:00, Lara Ro... | venturelab... |
24.08.2016 | Ten new Swiss startups selected to conquer China | | startuptic... |
24.08.2016 | Ten new Swiss startups selected to conquer China and its inv... | For Swiss startups, China is a key market to explore. With the necessity to increase the visibility ... | venturekic... |
11.02.2016 | Anmeldung für den Jungunternehmerpreis Nordwestschweiz 2016 ... | | startuptic... |
18.12.2014 | BioVersys is the first to achieve the seif Label | | startuptic... |
08.12.2014 | BioVersys achieves first milestone in project to fight tuber... | BioVersys achieves first milestone in project to fight tuberculosis 08.12.2014 17:00, Lara Rossi lin... | venturelab... |
08.12.2014 | BioVersys achieves first milestone in project to fight tuber... | BioVersys, 2008 venture kick winner and venture leader USA, announced together with the University o... | venturekic... |
04.12.2014 | BioVersys and Université de Lille achieve first milestone in... | | startuptic... |
02.12.2014 | BioVersys and Enamine Announce Extension of Drug Discovery C... | | startuptic... |
30.05.2014 | BioVersys collaborates with GlaxoSmithKline | | startuptic... |
05.02.2014 | BioVersys and SARomics join efforts to combat multidrug-resi... | | startuptic... |
05.12.2013 | Dispute between entrepreneurs and venture capitalists | | startuptic... |
02.10.2013 | David Livermore joins the advisory board of BioVersys | | startuptic... |
19.09.2013 | Insights and background information from the Top 100 Startup... | | startuptic... |
18.09.2013 | CTI supports new strategy to combat antibiotic resistance | | startuptic... |
18.09.2013 | Housetrip erneut an die Spitze der Top 100 Start-ups gewählt... | | startuptic... |
27.06.2013 | BioVersys AG closes oversubscribed Series A financing round | | startuptic... |
07.06.2013 | Biotech start-ups: trends, opportunities and challenges | | startuptic... |
29.10.2012 | Top 100 Startup 2012: Housetrip auf Platz 1 | | startuptic... |
28.09.2012 | ProteoMediX Winner of the Life Sciences Prize 2012 | The prize of CHF 10'000, awarded today for the ninth time, is under the patronage of the Swiss Biote... | startuptic... |
13.06.2012 | BKB und BLKB verstärken Förderung von Life Sciences Start-up... | | startuptic... |
18.05.2012 | Pix4d and SWISSto12 get the final 100'000 kick | The first round of the private funding initiative focused on the quality of the business ideas prese... | venturekic... |
10.05.2012 | 37th Swiss Venture Day | | startuptic... |
05.12.2011 | IMD announces 19 Winners of the Startup Competition | | startuptic... |
24.11.2011 | Clean-Tech und Life Sciences bei Pionierpreis vorn | | startuptic... |
03.11.2011 | BioVersys entwickelt sich zum Seriensieger | | startuptic... |
23.09.2011 | BioVersys Winner of the Life Sciences Prize 2011 | | startuptic... |
23.09.2011 | BioVersys Winner of the Life Sciences Prize 2011 | BioVersys Winner of the Life Sciences Prize 2011 23.09.2011 00:00, Thorsten Hainke linkedIn facebook... | venturelab... |
31.03.2011 | BioVersys raises CHF 2.5 millions in a Seed Financing round | | startuptic... |
02.12.2010 | CTI Start-up Label | | startuptic... |
- | BioVersys | “Antibiotic-resistant germs are among the most important medical threats of our day and age. ▷ Find ... | fastfounde... |